Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kensei Yamaguchi

Showing results (1-10 of 309) with videos related to

Pageof 31
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 16, 2011
[Chemotherapy-induced stomatitis and diarrhea]Shigenori Kadowaki, Kensei Yamaguchi
Therapeutic Advances in Medical Oncology|March 14, 2022
The dawn of precision medicine in diffuse-type gastric cancerAkira Ooki, Kensei Yamaguchi
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 16, 2021
The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberrationAkira Ooki, Kensei Yamaguchi
Cancers|June 18, 2020
Circulating Tumor DNA as a Novel Biomarker Optimizing Chemotherapy for Colorectal CancerHiroki Osumi, Eiji Shinozaki, Kensei Yamaguchi
Journal of the Anus, Rectum and Colon|February 4, 2021
Immunotherapy in Colorectal Cancer: Current and Future StrategiesAkira Ooki, Eiji Shinozaki, Kensei Yamaguchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 13, 2006
[Capecitabine]Kensei Yamaguchi, Tomotaka Shimamura, Masahiro Tada
Cancer Metastasis Reviews|May 28, 2025
Novel immunotherapy for gastric cancer: targeting the CD47-SIRPα axisAkira Ooki, Hiroki Osumi, Keitaro Shimozaki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 26, 2024
Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repairAkira Ooki, Hiroki Osumi, Koichiro Yoshino, et al.
Cancer Metastasis Reviews|July 8, 2023
Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinomaAkira Ooki, Hiroki Osumi, Koshiro Fukuda, et al.
Journal of Biochemistry and Molecular Biology|February 10, 2006
Carcinogenic role of tumor necrosis factor-alpha inducing protein of Helicobacter pylori in human stomachMasami Suganuma, Takashi Kuzuhara, Kensei Yamaguchi, et al.
Pageof 31

Showing results (1-10 of 309) with videos related to

Sort By:
Pageof 31
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 16, 2011
[Chemotherapy-induced stomatitis and diarrhea]Shigenori Kadowaki, Kensei Yamaguchi
Therapeutic Advances in Medical Oncology|March 14, 2022
The dawn of precision medicine in diffuse-type gastric cancerAkira Ooki, Kensei Yamaguchi
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 16, 2021
The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberrationAkira Ooki, Kensei Yamaguchi
Cancers|June 18, 2020
Circulating Tumor DNA as a Novel Biomarker Optimizing Chemotherapy for Colorectal CancerHiroki Osumi, Eiji Shinozaki, Kensei Yamaguchi
Journal of the Anus, Rectum and Colon|February 4, 2021
Immunotherapy in Colorectal Cancer: Current and Future StrategiesAkira Ooki, Eiji Shinozaki, Kensei Yamaguchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 13, 2006
[Capecitabine]Kensei Yamaguchi, Tomotaka Shimamura, Masahiro Tada
Cancer Metastasis Reviews|May 28, 2025
Novel immunotherapy for gastric cancer: targeting the CD47-SIRPα axisAkira Ooki, Hiroki Osumi, Keitaro Shimozaki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 26, 2024
Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repairAkira Ooki, Hiroki Osumi, Koichiro Yoshino, et al.
Cancer Metastasis Reviews|July 8, 2023
Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinomaAkira Ooki, Hiroki Osumi, Koshiro Fukuda, et al.
Journal of Biochemistry and Molecular Biology|February 10, 2006
Carcinogenic role of tumor necrosis factor-alpha inducing protein of Helicobacter pylori in human stomachMasami Suganuma, Takashi Kuzuhara, Kensei Yamaguchi, et al.
Pageof 31